Aquestive Therapeutics Inc
(AQST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 11,134 | 10,682 | 11,463 | 13,265 | 12,270 |
| Cost of Goods | 4,737 | 5,305 | 4,625 | 5,242 | 4,214 |
| Gross Profit | 6,397 | 5,377 | 6,838 | 8,023 | 8,056 |
| Operating Expenses | 11,739 | 16,395 | 16,316 | 21,027 | 18,008 |
| Operating Income | -4,605 | -10,713 | -8,853 | -12,762 | -9,738 |
| Interest Expense | 1,487 | 1,704 | 3,688 | 3,572 | 3,479 |
| Other Income | 14,160 | 65 | 5 | 32 | -3 |
| Pre-tax Income | 8,068 | -12,352 | -12,536 | -16,302 | -13,220 |
| Net Income Continuous | 8,068 | -12,352 | -12,536 | -16,302 | -13,220 |
| Net Income | $8,068 | $-12,352 | $-12,536 | $-16,302 | $-13,220 |
| EPS Basic Total Ops | 0.15 | -0.21 | -0.23 | -0.36 | -0.32 |
| EPS Basic Continuous Ops | 0.15 | -0.20 | -0.23 | -0.36 | -0.32 |
| EPS Diluted Total Ops | 0.11 | -0.21 | -0.23 | -0.36 | -0.32 |
| EPS Diluted Continuous Ops | 0.11 | -0.20 | -0.23 | -0.36 | -0.32 |
| EBITDA(a) | $-4,224 | $-10,258 | $-8,209 | $-12,026 | $-8,971 |